Overview
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Completed
Trial end date:
2003-08-01
2003-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertensionPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AllerganTreatments:
Bimatoprost
Timolol
Criteria
Inclusion Criteria:- Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
- Patient requires IOP-lowering drug in both eyes
Exclusion Criteria:
- Uncontrolled medical condition
- Contraindication to beta-adrenoceptor antagonist therapy